Literature DB >> 26550242

Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk.

Yuehua You1, Xinya Du2, Mingwen Fan1, Bin Wu2, Chun Xie2.   

Abstract

Interleukin-10 (IL-10) is likely to be closely correlated with the outbreak and progression of cancers though aiding tumors to free from the immune response. In previous studies, several polymorphisms sites including -1082A/G, -592A/C and -819T/C in the promoter region of IL-10 gene were proved to be involved in oral cancer. The purpose of this study was to further explore this association via a meta-analysis. There were four publications with 3783 cases and 4245 controls retrieved though electronic databases. The association among three IL-10 polymorphisms sites was estimated by summary odds ratios (ORs) and 95% confidence intervals (95% CIs) which were calculated using fixed-effect model. Subgroup analysis by ethnicity (Asian or Caucasian) was also performed for the analysis of IL-10-1082A/G polymorphism (three studies in Asians and one study in Caucasian). As a result, we found a moderately increased risk which was related to IL-10-1082A/G polymorphism in oral cancer under all the five contrasts [GG vs. AA: OR (95% CI)=2.95 (1.94-4.48); GG+AG vs. AA: OR (95% CI)=1.59 (1.35-1.86); GG vs. AG+AA: OR (95% CI)=2.59 (1.71-3.94); Allele G vs. Allele A: OR (95% CI)=1.68 (1.46-1.94); AG vs. AA: OR (95% CI)=1.53 (1.29-1.81)]. Additionally, the increased risk of oral cancer was also observed in Asians and Caucasians. However, the pooled data indicated that IL-10 -592A/C and -819T/C polymorphisms sites had no relationship with oral cancer risk. Taken together, the IL-10-1082A/G polymorphism site may act as a risk factor in oral cancer, and this issue still needs to be further verified.

Entities:  

Keywords:  Interleukin-10; oral cancer; polymorphism; susceptibility

Year:  2015        PMID: 26550242      PMCID: PMC4612927     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  46 in total

1.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

2.  Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus.

Authors:  J Eskdale; V Keijsers; T Huizinga; G Gallagher
Journal:  Genes Immun       Date:  1999-11       Impact factor: 2.676

3.  Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.

Authors:  Chia-Wen Tsai; Wen-Shin Chang; Kuo-Cheng Lin; Liang-Chun Shih; Ming-Hsui Tsai; Chieh-Lun Hsiao; Mei-Due Yang; Cheng-Chieh Lin; Da-Tian Bau
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

Review 4.  The structural network of inflammation and cancer: merits and challenges.

Authors:  Emine Guven Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov
Journal:  Semin Cancer Biol       Date:  2013-05-24       Impact factor: 15.707

5.  Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women.

Authors:  Ju Won Roh; Moon Hong Kim; Sang Soo Seo; Su Hyeong Kim; Jae Weon Kim; Noh Hyun Park; Yong Sang Song; Sang Yoon Park; Soon Beom Kang; Hyo Pyo Lee
Journal:  Cancer Lett       Date:  2002-10-08       Impact factor: 8.679

6.  Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.

Authors:  L Kozłowski; I Zakrzewska; P Tokajuk; M Z Wojtukiewicz
Journal:  Rocz Akad Med Bialymst       Date:  2003

Review 7.  Gene therapy for the treatment of oral squamous cell carcinoma.

Authors:  S Xi; J R Grandis
Journal:  J Dent Res       Date:  2003-01       Impact factor: 6.116

8.  Trial Watch: Immunostimulatory cytokines.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Alexander Eggermont; Jerome Galon; Eric Tartour; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-07-01       Impact factor: 8.110

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.

Authors:  M S Fahey; I C Paterson; A Stone; A J Collier; Y L Heung; M Davies; V Patel; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

View more
  3 in total

1.  Association between interleukin-10 gene polymorphisms and risk of oral carcinoma: A meta-analysis.

Authors:  Fan Li; Xing Xu; Chao Xuan; Wan-Tao Chen
Journal:  Histol Histopathol       Date:  2020-10-29       Impact factor: 2.303

2.  Association of interleukin 10 rs1800896 polymorphism with susceptibility to breast cancer: a meta-analysis.

Authors:  ZiYin Zhu; Ji-Bin Liu; Xi Liu; LinXue Qian
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

3.  Association of Interleukin-10 Genotypes and Oral Cancer Susceptibility in Selected Malaysian Population: A Case-zzm321990Control Study

Authors:  E V Soma Sekhar Goud; Shanthi Malleedi; Anand Ramanathan; Gou Rean Wong; Beatrix Tan Hwei Ern; Goh Yin Yean; Ho Hui Ann; Tan Yuen Syan; Rosnah Mohd Zain
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.